Análisis de la cuota de mercado y oportunidades de la terapia con ácidos nucleicos (2025-2031)
Nucleic Acid Therapeutics Market Report Analysis
Nucleic Acid Therapeutics Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Alnylam Pharmaceuticals, Inc.
- Silence Therapeutics plc
- Arbutus Biopharma Corporation
- Genzyme (Sanofi)
- Ionis Pharmaceuticals
- Sarepta Therapeutics
- Benitec Biopharma Inc.
- Arrowhead Pharmaceuticals
- Biogen, Inc.
Regional Overview
- América del Norte
- Europa
- Asia-Pacífico
- América del Sur y Central
- Medio Oriente y África
Market Segmentation
By Tipo
- Antagomir y esponja de ARN
- terapia con oligonucleótidos antisentido
- ácido nucleico bloqueado
- oligopéptido de ácido nucleico
- terapia con ARNi
- oligonucleótido formador de triplex.
By Aplicación
- trastornos genéticos
- trastornos autoinmunes
By Usuario final
- Institutos de investigación
- hospitales y clínicas.
By Geografía
- América del Norte
- Europa
- Asia-Pacífico
- América del Sur y Central
Get Free Sample For